Sichenzia Ross Ference LLP represented Aegis Capital Corp., as a sole bookrunner in the offering. Greenwich LifeSciences, Inc. (NASDAQ: GSLI) executed its initial public offering of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
